Last year, KORU Medical Systems Inc generated 27.99M USD for its biggest-performing segment, Domestic Core. The Domestic made the largest contribution, accounting for 30.24M USD last year. For the latest quarter, KORU Medical Systems Inc reported the revenue of 7.98M USD for the period ending 2026-06-30, which came from the top-performing segment, Domestic Core. Domestic contributed the highest revenue, at 8.40M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Domestic Core

International Core

Pharma services and clinical traials

Novel Therapies

FY2025

FY2024

FY2023

FY2022

Domestic Core

27.99M(64.53%)

25.21M(69.97%)

22.45M(74.84%)

21.21M(69.70%)

International Core

10.88M(25.08%)

6.04M(16.77%)

4.60M(15.32%)

4.16M(13.69%)

Pharma services and clinical traials

2.25M(5.20%)

2.39M(6.63%)

1.48M(4.92%)

2.53M(8.30%)

Novel Therapies

2.25M(5.20%)

2.39M(6.63%)

1.48M(4.92%)

2.53M(8.30%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

Domestic

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Domestic

30.24M(73.52%)

27.51M(81.75%)

23.68M(83.02%)

23.59M(84.55%)

19.49M(82.97%)

20.68M(85.53%)

International

10.89M(26.48%)

6.14M(18.25%)

4.84M(16.98%)

4.31M(15.45%)

4.00M(17.03%)

3.50M(14.47%)